Comprehensive Genetic Testing for Neurological Disorders Using Next-Generation Sequencing
The IVDNGS™ Extended Neuro Panel is a high-throughput, next-generation sequencing (NGS)-based assay developed for the detection of genetic mutations linked to a wide range of neurological and neurodevelopmental disorders. This in vitro diagnostic panel is optimized to identify pathogenic variants in genes associated with epilepsy, intellectual disability, movement disorders, neuromuscular conditions, autism spectrum disorders, and more.
Designed for clinical utility, the panel improves diagnostic efficiency, supports early intervention, and enables personalized treatment strategies.
Analysis of 500+ genes implicated in neurological disorders
Detection of SNVs, indels, CNVs, and splice-site mutations
High sensitivity and specificity using targeted NGS enrichment
Efficient workflow with automated data analysis pipeline
Reports include clinical interpretation, zygosity, and ACMG classification
Developed under ISO 13485 and IVD quality standards
Epilepsy and Seizure Syndromes
Autism Spectrum Disorders (ASD)
Intellectual and Developmental Delay
Hereditary Neuropathies and Ataxias
Neuromuscular and Mitochondrial Disorders
Neurodegenerative Conditions (e.g., ALS, Parkinsonism)
Pediatric-onset and Adult-onset Neurogenetic Disorders
| Parameter | Details |
|---|---|
| Sample Type | EDTA whole blood / saliva / extracted DNA |
| Turnaround Time | 2–3 weeks (standard) |
| DNA Input | ≥ 50 ng |
| Sequencing Platform | Illumina / Equivalent NGS platforms |
| Report Format | Annotated variant report + clinical correlation |
Copyright © 2025 https://probgenbiotech.com/ All Rights Reserved.